(IMNM) Immunome - Performance -25.7% in 12m
IMNM performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-37.06%
#55 in Peer-Group
Rel. Strength
18.27%
#6274 in Stock-Universe
Total Return 12m
-25.73%
#90 in Peer-Group
Total Return 5y
-33.46%
#52 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 16.51 USD |
| 52 Week Low | 5.56 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 63.00 |
| Buy/Sell Signal +-5 | 0.78 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: IMNM (-25.7%) vs XBI (-7.4%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
4.78% | 72% | 82.5% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
6.68% | -8.84% | 159% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.37% | -3.61% | 40.4% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-0.33% | 33.2% | -0.68% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
8.13% | -8.29% | 7.01% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
14.7% | 39.8% | -2.94% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.29% | 55.9% | -6.21% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
3.06% | 28.4% | 19% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: IMNM vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for IMNM
| Total Return (including Dividends) | IMNM | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -6.48% | 3.64% | 4.08% |
| 3 Months | 44.35% | 23.43% | 19.65% |
| 12 Months | -25.73% | -7.41% | 12.88% |
| 5 Years | -33.46% | -20.74% | 113.48% |
| Trend Score (consistency of price movement) | IMNM | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -58.4% | 30.3% | 86.9% |
| 3 Months | 67.9% | 79.4% | 97.2% |
| 12 Months | -88% | -87.3% | 46% |
| 5 Years | -14.4% | -52.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th32.00 | -9.77% | -10.14% |
| 3 Month | %th69.00 | 16.95% | 20.64% |
| 12 Month | %th55.00 | -19.79% | -34.20% |
| 5 Years | %th75.50 | -17.18% | -66.82% |
FAQs
Does Immunome (IMNM) outperform the market?
No,
over the last 12 months IMNM made -25.73%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.41%.
Over the last 3 months IMNM made 44.35%, while XBI made 23.43%.
Performance Comparison IMNM vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
IMNM vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 1.2% | -10.6% | -24% | -39% |
| US NASDAQ 100 | QQQ | 1.4% | -10.6% | -25.4% | -37% |
| German DAX 40 | DAX | -1% | -8.4% | -36.1% | -58% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -0.3% | -11.8% | -28.4% | -47% |
| Hongkong Hang Seng | HSI | 2.4% | -9% | -44.3% | -63% |
| India NIFTY 50 | INDA | 2.2% | -6.5% | -23.5% | -24% |
| Brasil Bovespa | EWZ | 6.7% | -8.3% | -40% | -28% |
IMNM vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 2.5% | -8.6% | -27.5% | -49% |
| Consumer Discretionary | XLY | 1.2% | -9% | -16.3% | -42% |
| Consumer Staples | XLP | 2.5% | -6.4% | -23.1% | -33% |
| Energy | XLE | -0.7% | -11.6% | -17.6% | -28% |
| Financial | XLF | 2.1% | -10.1% | -27.8% | -53% |
| Health Care | XLV | 0.6% | -7.4% | -14% | -20% |
| Industrial | XLI | 0.4% | -11.4% | -31.1% | -51% |
| Materials | XLB | 0.3% | -10.8% | -27.4% | -32% |
| Real Estate | XLRE | 1.7% | -5.9% | -23.4% | -37% |
| Technology | XLK | 1.2% | -13.4% | -28.3% | -35% |
| Utilities | XLU | 0.4% | -9.3% | -26.4% | -48% |
| Aerospace & Defense | XAR | 0.9% | -13% | -42.2% | -74% |
| Biotech | XBI | -2.4% | -10.1% | -14.4% | -18% |
| Homebuilder | XHB | -2.1% | -14.8% | -19.7% | -32% |
| Retail | XRT | 0.9% | -9.2% | -18.5% | -37% |
IMNM vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 1% | -11.8% | -9.06% | -19% |
| Natural Gas | UNG | 4.5% | 1.7% | 4.4% | -21% |
| Gold | GLD | 1.6% | -6.3% | -38.9% | -65% |
| Silver | SLV | 0.5% | -8% | -37.8% | -46% |
| Copper | CPER | -7.8% | -19.8% | -45% | -48% |
IMNM vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 1.2% | -8.2% | -19.6% | -24% |
| iShares High Yield Corp. Bond | HYG | 1.5% | -7.7% | -20.6% | -35% |